1. Home
  2. Live Updates
  3. Covaxin for children

Live Breaking News & Updates on Covaxin for children

Stay informed with the latest breaking news from Covaxin for children on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covaxin for children and stay connected to the pulse of your community

Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

SEC has recommended restricted emergency use of Biological E's COVID-19 vaccine, Corbevax, in children aged 5-12 years

India , New-delhi , Delhi , Bharat , Expert-committee , Subject-expert-committee , Drug-controller-general , Bharat-biotech , Covaxin-for-children , Ovid-vaccination-for-children , Ovaxin-data

Covaxin Safe For Kids Aged 2-18, Here's What Bharat Biotech Says On Side-Effects Of Its Covid Vaccine After Trial Data

Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16

India , Bharat , Krishna-ella , Central-drugs-standard-control-organisation , Bharat-biotech , Lancet-infectious-diseases , Covaxin-bharat-biotech , Covaxin-for-children , Covaxin-coronavirus-vaccine ,

COVID-19 update: Covovax now available for children in India, says Adar Poonawalla

Poonawalla said, "This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > (more than) 90%."

India , Narendra-modi , Adar-poonawalla , Twitter , National-technical-advisory-group-on-immunisation , Serum-institute-of-india , Serum-institute , Prime-minister-narendra-modi , National-technical-advisory-group , Bharat-biotech , Covovax , Covavax-for-india

Covaxin For Kids: Bharat Biotech's Covaxin Cleared For 6-12 Age Group By Drugs Regulator

The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.

India , Bharat , Drugs-controller-general , Bharat-biotech , Emergency-use-listing , Covaxin , Covaxin-for-children , Covid-19 , Corbevax ,

DCGI grants EUA to 3 Covid vaccines for different age group of children

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups.

India , Zycovd-zydus-cadila , Mansukh-mandaviya , Union-health , Expert-committee , Drugs-controller-general , Bharat-biotech , Zydus-cadila , Restricted-use , Emergency-situations , Health-minister-mansukh-mandaviya , Subject-expert-committee

Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

SEC has recommended restricted emergency use of Biological E's COVID-19 vaccine, Corbevax, in children aged 5-12 years

India , New-delhi , Delhi , Bharat , Expert-committee , Subject-expert-committee , Drug-controller-general , Bharat-biotech , Covaxin-for-children , Ovid-vaccination-for-children , Ovaxin-data

Covaxin for Children Proven to be Safe in Phase II/III Study

Covaxin was proven to be safe, well-tolerated, in children who took part in phase II/III study.

India , Bharat , Bharat-biotech , Covaxin-for-children , Ovaxin , Ovaxins-clinical-trial , Ovaxin-for-children-trial ,

Data From Trials On 2-18-Year-Olds Very Encouraging: Covaxin Maker

Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.

India , Bharat , Krishna-ella , Central-drugs-standard-control-organisation , Year-olds-very-encouraging , Covaxin-maker , Bharat-biotech , Managing-director , National , Covaxin-for-children ,

Covaxin Gets Approval for Emergency Use for Children Aged 12-18

Bharat Biotech's Covaxin gets approval from the Drug Controller General of India (DGCI) for emergency use for children aged between 12-18 years.

Weight-kidsemergencyalarming-facts , Road-traffic-accidentsroad-accidents , Road-safetywomen-more-prone , Covaxin-for-children , Ovid-vaccine-for-kids , Bv152 , Ovid-cases-in-india , Micron-positive-cases , Dsco ,

After Zydus Cadila's ZyCoV-D, Covaxin Jab Cleared For Children Aged 12

The Drug Controller General of India (DCGI) on Saturday approved Bharat Biotech's COVID-19 vaccine Covaxin for emergency use on children between the ages of 12 and 18. The vaccine is not for children below 12 years. India will start rolling out vaccines for children in the age group of 15 to 18 years from January 3. Covaxin is the second vaccine cleared for use on children in

India , Bharat , Zydus-cadila-zyco , Covaxin-to-central-drugs-standard-control-organisation , Serum-institute-novavax , Drug-controller-general , Bharat-biotech , Zydus-cadila , Central-drugs-standard-control-organisation , Whole-virion , Serum-institute